Lp(a) measurement bias
Over and underestimation of Lp(a) due to its different molecular weight isoforms has led to bias in many studies leading to underestimation of its strength as a cardiovascular risk factor.
Dr Michael France is a Chemical Pathologist with a specialist interest in Lipidology and will present at the HEART UK virtual conference on 7 July.
He has worked with HEART UK in producing consensus guidelines for management of homozygous familial hypercholesterolaemia and Lipoprotein (a) testing. He has published widely in the field of Lipidology and Clinical Biochemistry and has a particular interest in the diagnostic utility of laboratory tests.
See the full conference programme on the Health professionals section of the website. The Health Professional area of the website is intended only for healthcare professionals.
This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies
Related stories
- Lipoprotein (a) disorder gets SNOMED codes
- Would you like to update your knowledge of lipid management and have the opportunity to liaise with others working in this area?
- Familial Hypercholesterolaemia Gene Testing One-Day Online Workshop - Dates for 2023
- New SNOMED Codes for FH DNA test results!
- Healthcare Professional Dietary Survey Prize Draw 2022
- Opportunity to join the NICE CG181 guideline committee
- NICE launches review of methods and processes for health technology evaluation
- The Essential Cholesterol Programme for Primary Care
- Add on to take back control. Do we have the solutions to the gaps in our lipid treatment pathway?
- Familial Hypercholesterolaemia: from Epidemiology to Genetics – a paradigm shift?